Cogent Biosciences Inc (NASDAQ: COGT) kicked off on Thursday, up 2.34% from the previous trading day, before settling in for the closing price of $4.27. Over the past 52 weeks, COGT has traded in a range of $3.72-$12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.00%. While this was happening, its average annual earnings per share was recorded 9.38%. With a float of $95.39 million, this company’s outstanding shares have now reached $110.46 million.
Let’s determine the extent of company efficiency that accounts for 205 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 16.22%, while institutional ownership is 91.52%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.60% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Take a look at Cogent Biosciences Inc’s (COGT) current performance indicators. Last quarter, stock had a quick ratio of 5.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 1.62 million, which is a jump from its year-to-date volume of 1.45 million. As of the previous 9 days, the stock’s Stochastic %D was 48.12%. Additionally, its Average True Range was 0.53.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 9.52%, which indicates a significant decrease from 23.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.51% in the past 14 days, which was higher than the 72.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.74, while its 200-day Moving Average is $8.92. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $4.45. Second resistance stands at $4.53. The third major resistance level sits at $4.65. If the price goes on to break the first support level at $4.24, it is likely to go to the next support level at $4.12. Should the price break the second support level, the third support level stands at $4.04.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
The company with the Market Capitalisation of 497.52 million has total of 113,850K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -255,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -67,930 K.
